Lyell Immunopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lyell Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • Lyell Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 256M shares, a 1.99% increase year-over-year.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 251M shares, a 1.58% increase from 2022.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 247M shares, a 81.8% increase from 2021.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 136M shares, a 925% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 251M +3.9M +1.58% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 247M +111M +81.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 136M +123M +925% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 13.3M +13.3M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 5.43K* Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.